DHR | ||
---|---|---|
OUTLOOK RATING 1..100 | 70 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 62 Fair valued | |
PROFIT vs RISK RATING 1..100 | 82 | |
SMR RATING 1..100 | 79 | |
PRICE GROWTH RATING 1..100 | 60 | |
P/E GROWTH RATING 1..100 | 66 | |
SEASONALITY SCORE 1..100 | 75 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CURE | DHR | |
---|---|---|
RSI ODDS (%) | N/A | N/A |
Stochastic ODDS (%) | 3 days ago85% | 3 days ago67% |
Momentum ODDS (%) | 3 days ago83% | 3 days ago61% |
MACD ODDS (%) | 3 days ago90% | 3 days ago70% |
TrendWeek ODDS (%) | 3 days ago90% | 3 days ago61% |
TrendMonth ODDS (%) | 3 days ago90% | 3 days ago56% |
Advances ODDS (%) | 3 days ago90% | 10 days ago55% |
Declines ODDS (%) | 11 days ago90% | 4 days ago59% |
BollingerBands ODDS (%) | 6 days ago90% | 3 days ago59% |
Aroon ODDS (%) | 3 days ago90% | 3 days ago56% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
LIGGX | 11.59 | 0.07 | +0.61% |
Loomis Sayles International Growth A | |||
CEIZX | 14.10 | 0.07 | +0.50% |
Manning & Napier Callodine Equity Inc Z | |||
BMSYX | 15.50 | N/A | N/A |
MFS Blended Research Mid Cap Eq R6 | |||
CHDVX | 14.38 | -0.04 | -0.28% |
Cullen High Dividend Equity I | |||
ILGRX | 43.15 | -0.22 | -0.51% |
Macquarie Large Cap Growth Fund R6 |